Roivant Sciences Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley from the team.
Our next presenting company is Roivant. And presenting on behalf of the company, we have CEO, Matthew Gline. Before I turn it over to Matthew, I just wanted to highlight to all of our listeners to please use the ask a question feature in the portal to ask any of your questions, and I'll get it in on your behalf. With that, I'd like to hand it over to you, Matthew.
Thank you. Appreciate it, and good afternoon, everybody. Thank you for having me at the conference. I'm going to start today with a presentation outlining a little bit about Roivant and some of the things we're working on, and then we'll end with some time for Q&A. So thank you very much.
I think the slides are self advanced, so I'll call out slide
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
